SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-069655
Filing Date
2015-09-04
Accepted
2015-09-04 16:16:19
Documents
1
Period of Report
2015-09-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3693
  Complete submission text file 0001209191-15-069655.txt   5011
Mailing Address 6475 CHRISTIE AVENUE SUITE 300 EMERYVILLE CA 94608
Business Address
Bertolino Arthur Peter (Reporting) CIK: 0001426344 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 151094773

Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations